Following the results of an extensive survey by researchers at Arizona State University and the University of Texas-Houston, medical professionals and parents now have a better guide for treating ...

According to the Centers for Disease Control and Prevention (CDC), about 1 out of 10 people will have a seizure during their lifetime. Most of these seizures will be epileptic seizures, which are ...

Researchers from Inserm and Grenoble Alpes University (UGA) have discovered a new therapeutic avenue for combating drug-resistant epilepsies. Fractionated administration of microbeam X-rays induces ...

Dr Pavel Klein discusses strategies to address patient skepticism and improve seizure reporting to enhance clinical outcomes in epilepsy.

CAMBRIDGE, Mass. & BARCELONA, Spain--(BUSINESS WIRE)--Neuroelectrics, a clinical-stage company pioneering brain stimulation therapies, has been granted FDA Breakthrough Device Designation for its ...

A surgical treatment commonly used to reduce epileptic seizures in adults also is effective and safe for children, according to a new study. The study is one of the first to investigate responsive ...

There are many types of epilepsy, a brain disorder that causes recurrent seizures or periods of altered behaviors or sensations. Around one percent of the world's population is thought to be impacted, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among those deemed “treatment sensitive,” 69.4% ...

Keeping newborns on antiseizure medication after acute neonatal seizures stopped did not change development outcomes or prevent epilepsy, a comparative effectiveness study showed. No difference was ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The Cleveland ...

Please provide your email address to receive an email when new articles are posted on . In the TELSTAR open-label trial, Ruijter and colleagues analyzed data from 172 comatose survivors of cardiac ...